🕵️ Lexaria Bioscience Corp. ($LEXX)
SEC insider & ownership activity, last 12 months · CIK 1348362 · every row links its SEC filing
Over the last 12 months insiders bought $49K with no open-market selling against it. Bunka Christopher bought $25K in discretionary trades (Jul). One red-flag 8-K in the window: Delisting notice (3.01), Feb 4, 2026.
Insider flow
5 buyers, $49K (6 lots) · 0 sellers, $0 (0 lots)
| Insider | Buys | Bought | Sells | Sold | Last |
|---|---|---|---|---|---|
| Bunka Christopher | 2 | $25K | 0 | – | Jul 30, 2025 |
| Christopher Richard | 1 | $14K | 0 | – | Jul 29, 2025 |
| Docherty John Martin | 1 | $5K | 0 | – | Jul 29, 2025 |
| McKechnie William Edward | 1 | $5K | 0 | – | Jul 29, 2025 |
| Carle Vanessa | 1 | $682 | 0 | – | Jul 29, 2025 |
5%+ holders
No current 5%+ beneficial-ownership positions on file.
Planned insider sales (Form 144)
No sale notices filed in the last 12 months.
Material events (8-K)
| Item | Event date | |
|---|---|---|
| Delisting notice (3.01) | Feb 4, 2026 | filing ↗ |
| Shareholder vote (5.07) | Jan 27, 2026 | filing ↗ |
| Material agreement (1.01) | Dec 14, 2025 | filing ↗ |
| Unregistered equity sale (3.02) | Dec 14, 2025 | filing ↗ |
| Other events (8.01) | Dec 14, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Dec 14, 2025 | filing ↗ |
| Material agreement (1.01) | Sep 26, 2025 | filing ↗ |
| Unregistered equity sale (3.02) | Sep 26, 2025 | filing ↗ |
| Other events (8.01) | Sep 26, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Sep 26, 2025 | filing ↗ |
| Agreement terminated (1.02) | Sep 19, 2025 | filing ↗ |